Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Your pancreas may be making its own version of Ozempic

Half Quit “Miracle” Weight-Loss Shots Ozempic and Wegovy Within One Year

People on Ozempic who eat to regulate emotions less likely to lose weight, research reveals

People on Ozempic who eat to regulate emotions less likely to lose weight - EurekAlert!

Ozempic, Wegovy and Mounjaro makes food taste sweeter and saltier, and that may quiet cravings

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before - EurekAlert!

Popular Weight-Loss Drugs Like Ozempic Pose Hidden Risks for Young Women, Warn Researchers

Ozempic’s hidden pregnancy risk few women know about

Drugs like Ozempic might lower cancer risk

The next Ozempic: A 4-in-1 breakthrough for lasting weight loss

Quit Ozempic or Wegovy? Here’s How Fast the Pounds Can Come Back

Is Ozempic Sapping Your Strength? Research Shows Surprising Muscle Loss

Could This Tiny Molecule Be Better Than Ozempic and Wegovy for Obesity?

Losing weight but gaining weakness? What Ozempic might be doing to your muscles

What really happens to your body when you stop weight loss drugs like Ozempic

We should consider testing Ozempic on healthy people

Weight loss drug Ozempic could protect the brain from stroke

Ozempic really could turn back the clock on your biological age

Weight Comes Back When You Stop Taking Drugs Like Ozempic, Study Finds

An injected gel could make drugs like Ozempic last longer